Astellas Plots Near-Term Moves to Execute Long-Term Vision in Gene Therapy
Astellas has become an active player in gene therapy. MedCity News caught up with company executive Richard Wilson, who explained Astellas’s strategy, the clinical holds on its two most advanced programs, and the rationale behind its recent gene therapy deals.
Information Courtesy By: Frank Vinluan, #HealthcareNews #Healthcare | Feeds
Astellas has become an active player in gene therapy. MedCity News caught up with company executive Richard Wilson, who explained Astellas’s strategy, the clinical holds on its two most advanced programs, and the rationale behind its recent gene therapy deals.
Click For More Details
2023-01-25 05:53
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.